Non-invasive prenatal testing (NIPT) offers women safer and more reliable options for prenatal screening compared to traditional screening methods. It analyzes cell-free DNA from a simple blood draw of the mother to screen for common genetic conditions like Down syndrome with high accuracy. The rising cases of pregnancies affected by chromosomal abnormalities have boosted the demand for NIPT across North Africa.

The North Africa Non-Invasive Prenatal Testing Market is estimated to be ... Read more

The North Africa non-invasive prenatal testing (NIPT) market is comprised of prenatal screening tests that analyze cell-free DNA from a maternal blood sample to screen for genetic abnormalities in a fetus. Non-invasive prenatal testing analyzes specific fetal DNA and RNA fragments found in the mother's bloodstream and provides a safer alternative to invasive tests like amniocentesis. It screens for Down syndrome, Edwards syndrome, Patau syndrome and sex chromosome abnormalities like ... Read more

Non-invasive prenatal testing (NIPT) has become widely adopted in developed nations around the world as a reliable method for screening for common chromosomal abnormalities like Down syndrome early in pregnancy without medical risks to the mother or fetus. Now, this innovative technology is making its way to the developing regions of North Africa, providing new hope and choices for expectant parents in the region.

Introduction of NIPT in North Africa
... Read more